Relationships of leukocyte metabolism to Clostridium botulinum pathogenicity.
D000818:Animals; D001386:Azides / Q000494:pharmacology; D001904:Botulinum Antitoxin / Q000494:pharmacology; D001905:Botulinum Toxins / Q000378:metabolism; D002127:Calcium Isotopes; D003014:Clostridium botulinum / Q000254:growth & development / Q000472:pathogenicity*; D003078:Colchicine / Q000494:pharmacology; D003470:Culture Media; D005985:Glyceraldehyde / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D006168:Guinea Pigs; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D008713:Methimazole / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D010587:Phagocytosis / Q000187:drug effects; D013171:Spores, Bacterial / Q000254:growth & development; D013997:Time Factors
D001386:Azides; D001904:Botulinum Antitoxin; D002127:Calcium Isotopes; D003470:Culture Media; D005985:Glyceraldehyde; D008713:Methimazole; D001905:Botulinum Toxins; D003078:Colchicine